Gold nanoparticle sensors for detecting chronic kidney disease and disease progression

Nanomedicine

Volumn 7, Issue 5, 2012, Pages 639-650

  Marom, Ophir ^a   Nakhoul, Farid ^a,b   Tisch, Ulrike ^a   Shiban, Ala ^a   Abassi, Zaid ^a,c   Haick, Hossam ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

^c Research Unit   (Israel)

Author keywords

breath; chronic kidney disease; gold nanoparticle; sensor; staging; volatile organic compound

Indexed keywords

GOLD NANOPARTICLE; TOXIN;

ACCURACY; ADULT; AIR BREATHING SPECIES; ARTICLE; BIOSENSOR; CHEMICAL COMPOSITION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; GAS CHROMATOGRAPHY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOSENSING TECHNIQUES; BREATH TESTS; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; GOLD; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NANOPARTICLES; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINES;

EID: 84861599730     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.135     Document Type: Article

References (52)

1. Hall YN, Chertow GM. End stage renal disease. Clin. Evid. 15, 1171-1181 (2006).
2. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: defnitions, diagnosis, pathogenesis and therapy. J. Clin. Invest. 114, 5-14 (2004). (Pubitemid 39071636)
3. Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner. Electrolyte Metab. 17, 124-132 (1991).
4. Levey AS, Andreoli SP, DuBose T, Provenzano R, Allan J, Collins AJ. Chronic kidney disease: common, harmful and treatable-world kidney day 2007. Am. J. Nephrology 27, 108-112 (2007). (Pubitemid 46364548)
5. Levey AS, Eckardt KU, Tsukamoto Y et al. Defnition and classifcation of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 67(6), 2089-2100 (2005). (Pubitemid 41623371)
6. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int. Suppl. 87, S24-S31 (2003). (Pubitemid 37315504)
7. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classifcation, and stratifcation. Ann. Intern. Med. 139(2), 137-149 (2003).
8. Hirsch S. Preventing end-stage renal disease: fexible strategies to overcome obstacles. Curr. Opin. Nephrol. Hypertens. 15(5), 473-480 (2006).
9. Vanholder R, Baurmeister U, Brunet P, Cohen G, Glorieux G, Jankowski J. A bench to bedside view of uremic toxins. J. Am. Soc. Nephrol. 19(5), 863-870 (2008).
10. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P. Protein-bound toxins-update 2009. Semin. Dial. 22(4), 334-339 (2009).
11. Meyer TW, Hostetter TH. Uremia. N. Engl. J. Med. 357(13), 1316-1325 (2007).
12. Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury Nephrology 15(4), 419-428 (2010).
13. Peng G, Hakim M, Broza YY et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer 103, 542-551 (2010).
14. Songa G, Qina T, Liua H et al. Quantitative breath ana lysis of volatile organic compounds of lung cancer patients. Lung Cancer 67, 227-231 (2010).
15. de Gennaro G, Dragonieri S, Longobardi F et al. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure. Anal. Bioanal. Chem. 398(7-8), 3043-3050 (2010).
16. Natale CD, Mantini A, Macagnano A, Antuzzi D, Paolesse R, D'Amico A. Electronic nose ana lysis of urine samples containing blood. Physiol. Meas. 20, 377-384 (1999).
17. Moorhead KT, Hill JV, Chase JG et al. Modelling acute renal failure using blood and breath biomarkers in rats. Comput. Methods Programs Biomed. 101(2), 173-182 (2011).
18. Lin Y-J, Guo H-R, Chang Y-H, Kao M-T, Wang H-H, Hong R-I. Application of the electronic nose for uremia diagnosis. Sens. Actuators B 76(1), 177-180 (2001). (Pubitemid 32513877)
19. Fend R, Bessant C, Williams AJ, Woodman AC. Monitoring haemodialysis using electronic nose and chemometrics. Biosens. Bioelectron. 19(12), 1581-1590 (2004). (Pubitemid 38622228)
20. Voss A, Baier V, Reisch R et al. Smelling renal dysfunction via electronic nose. Ann. Biomed. Eng. 33(5), 656-660 (2005). (Pubitemid 40890926)
21. Wang P, Tan Y, Xie H, Shen F. A novel method for diabetes diagnosis based on electronic nose. Biosens. Bioelectron. 12(9-10), 1031-1036 (1997).
22. Simenhoff ML, Burke JF, Saukkonen JJ, Ordinario AT, Doty R. Biochemical profle or uremic breath. N. Engl. J. Med. 297(3), 132-135 (1977).
23. Amann A, Poupart G, Telser S, Ledochowski M, Schmid A, Mechtcheriakov S. Applications of breath gas ana lysis in medicine. Int. J. Mass. Spectrom. 239(2-3), 227-233 (2004).
24. Buszewski B, Kesy M, Ligor T, Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed. Chromatogr. 21(6), 553-566 (2007). (Pubitemid 46937852)
25. Mazzone P. Progress in the development of a diagnostic test for lung cancer through the ana lysis of breath volatiles. J. Breath. Res. 2(3), 037014. (2008).
26. Tisch U, Haick H. Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev. Chem. Eng. 26, 171-179 (2011).
27. Amann A, Miekisch W, Pleil J, Risby T, Schubert J. Chapter 7: Methodological Issues of Sample Collection and Ana lysis of Exhaled Breath. Maney Publishing, Leeds, UK, 49, 96-114 (2010).
28. Haick H, Hakim M, Patrascu M et al. Sniffng chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano 3(5), 1258-1266 (2009).
29. Peng G, Trock E, Haick H. Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. Nano. Lett. 8(11), 3631-3635 (2008).
30. Peng G, Tisch U, Adams O et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat. Nanotechnol. 4(10), 669-673 (2009).
31. Dovgolevsky E, Haick H. Direct observation of the transition point between quasi-spherical and cubic nanoparticles in two-step seed-mediated growth method. Small 4(11), 2059-2066 (2008).
32. Dovgolevsky E, Tisch U, Haick H. Chemically sensitive resistors based on monolayer-capped cubic nanoparticles: towards confgurable nanoporous sensors. Small 5(10), 1158-1161 (2009).
33. Dovgolevsky E, Konvalina G, Tisch U, Haick H. Monolayer-capped cubic platinum nanoparticles for sensing nonpolar analytes in highly humid atmospheres. J. Phys. Chem. C 114(33), 14042-14049 (2010).
34. Haick H. Chemical sensors based on molecularly modifed metallic nanoparticles. J. Phys. D 40, 7173-7186 (2007). (Pubitemid 350147854)
35. Cortes C, Vapnik V. Support-vector networks. Machine Learning 30(3), 273-297 (1995).
36. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH. The WEKA data mining software: an update. SIGKDD Explorations 11(1), 10-18 (2009).
37. Rock F, Barsan N, Weimar U. Electronic nose: current status and future trends. Chem. Rev. 108(2), 705-725 (2008). (Pubitemid 351344454)
38. Amann A, Spanel P, Smith D. Breath ana lysis: the approach towards clinical applications. Mini Rev. Med. Chem. 7(2), 115-129 (2007). (Pubitemid 46592175)
39. Hakim M, Billan S, Tisch U et al. Diagnosis of head-and-neck-cancer from exhaled breath. Br. J. Cancer 104, 1649-1655 (2011).
40. Tisch U, Haick H. Nanomaterials for cross-reactive sensor arrays-an invited review. MRS Bull. (35), 797-803 (2010).
41. Rigalleau V, Gin H. Carbohydrate metabolism in uraemia. Curr. Opin. Clin. Nutr. Metab. Care 8(4), 463-469 (2005). (Pubitemid 40863064)
42. Mak RH. Insulin and its role in chronic kidney disease. Pediatr. Nephrol. 23(3), 355-362 (2008). (Pubitemid 351168112)
43. Contreras I, Caro J, Aveledo L, Diaz K, Durrego P, Weisinger J. In chronic uremia, insulin activates receptor kinase but not pyruvate dehydrogenase. Nephron 61(1), 77-81 (1992).
44. Folli F, Sinha MK, Brancaccio D, Caro JF. Insulin resistance in uremia: in vitro model in the rat liver using human serum to study mechanisms. Metabolism 35(11), 989-998 (1986). (Pubitemid 17186300)
45. Murray RK, Bender DA, Botham KM, Kenellu PJ, Rodwell V W, Weil PA. Harper's Illustrated Biochemistry. The McGraw-Hill Companies, NY, USA (2009).
46. Galloway R, Morgan J. Serum pyruvate and lactate in uremia. Metabolism 13, 818-822 (1964).
47. Thölen H, Bigler F, Staub H. Pathogenesis of the uremic syndrome. Pharmacological studies on acetoin and 2, 3-butylene glycol. Cell. Mol. Life Sci. 17(8), 359-360 (1961).
48. Heierli C, Thölen H. Metabolites of glucose in the blood of patients with renal failure. Klin. Wochenschr. 59(9), 431-436 (1981). (Pubitemid 11096661)
49. Lockley DJ, Howes D, Williams FM. Cutaneous metabolism of glycol ethers. Arch. Toxicol. 79(3), 160-168 (2005).
50. Lorenzi R, Andrades ME, Bortolin RC, Nagai R, Dal-Pizzol F, Moreira JCF. Circulating glycolaldehyde induces oxidative damage in the kidney of rats. Diabetes Res. Clin. Pract. 89(3), 262-267 (2010).
51. Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med. Toxicol. 1(5), 309-334 (1986). (Pubitemid 17170240)
52. Terre'Blanche G, Heyer N, Bergh JJ, Mienie LJ, van der Schyf CJ, Harvey BH. The styrene metabolite, phenylglyoxylic acid, induces striatal-motor toxicity in the rat: infuence of dose escalation/reduction over time. Neurotox. Res. 20(1), 97-101 (2011).